Jennifer RIGGS

Person

Cardiff, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 11,292,796
- Issue date Apr 5, 2022
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 10,683,298
- Issue date Jun 16, 2020
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 10,167,290
- Issue date Jan 1, 2019
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,795,607
- Issue date Oct 24, 2017
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 9,771,371
- Issue date Sep 26, 2017
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating a cancer using substituted pyrrolopyrimidine co...
- Patent number 9,623,028
- Issue date Apr 18, 2017
- Signal Pharmaceuticals, LLC
- Dan Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,428,509
- Issue date Aug 30, 2016
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,346,812
- Issue date May 24, 2016
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Halogen substituted pyrazines as intermediates of mTOR kinase inhib...
- Patent number 9,193,692
- Issue date Nov 24, 2015
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of synthesis and purification of heteroaryl compounds
- Patent number 9,079,900
- Issue date Jul 14, 2015
- Signal Pharmaceuticals, LLC
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 8,907,087
- Issue date Dec 9, 2014
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of synthesis and purification of heteroaryl compounds
- Patent number 8,569,494
- Issue date Oct 29, 2013
- Signal Pharmaceuticals, LLC
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...
- Patent number 8,507,492
- Issue date Aug 13, 2013
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...
- Patent number 8,492,381
- Issue date Jul 23, 2013
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment using heteroaryl compounds and compositions th...
- Patent number 8,383,634
- Issue date Feb 26, 2013
- Signal Pharmaceuticals, LLC
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment comprising the administration of heteroaryl co...
- Patent number 8,372,976
- Issue date Feb 12, 2013
- Signal Pharmaceuticals, LLC
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminotriazolopyridines, compositions thereof, and methods of treatm...
- Patent number 8,299,056
- Issue date Oct 30, 2012
- Signal Pharmaceuticals, LLC
- Sogole Bahmanyar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indicat...
- Patent number 8,110,578
- Issue date Feb 7, 2012
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds, compositions thereof, and methods of treatmen...
- Patent number 7,981,893
- Issue date Jul 19, 2011
- Signal Pharmaceuticals, LLC
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl compounds, compositions thereof, and methods of treatmen...
- Patent number 7,968,556
- Issue date Jun 28, 2011
- Signal Pharmaceuticals, LLC
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
WEE1 Degrading Compounds and Uses Thereof
- Publication number 20240067632
- Publication date Feb 29, 2024
- Bristol-Myers Squibb Company
- John Sapienza
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20230119470
- Publication date Apr 20, 2023
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20200262840
- Publication date Aug 20, 2020
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20190077806
- Publication date Mar 14, 2019
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20170342080
- Publication date Nov 30, 2017
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE CO...
- Publication number 20170173024
- Publication date Jun 22, 2017
- Signal Pharmaceuticals, LLC.
- Dan ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...
- Publication number 20160324861
- Publication date Nov 10, 2016
- Signal Pharmaceutical, LLC
- Andrew Antony Calabrese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20160024101
- Publication date Jan 28, 2016
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE CO...
- Publication number 20160008365
- Publication date Jan 14, 2016
- Signal Pharmaceuticals, LLC.
- Dan ZHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20150051397
- Publication date Feb 19, 2015
- Signal Pharmaceuticals, LLC.
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...
- Publication number 20140200207
- Publication date Jul 17, 2014
- Signal Pharmaceutical LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...
- Publication number 20140200206
- Publication date Jul 17, 2014
- Signal Pharmaceutical LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20140155593
- Publication date Jun 5, 2014
- Signal Pharmaceuticals, LLC.
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20130289271
- Publication date Oct 31, 2013
- Signal Pharmaceuticals, LLC.
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20130245254
- Publication date Sep 19, 2013
- Signal Pharmaceuticals, LLC.
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATM...
- Publication number 20130005707
- Publication date Jan 3, 2013
- Sogole Bahmanyar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...
- Publication number 20120071658
- Publication date Mar 22, 2012
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...
- Publication number 20120059164
- Publication date Mar 8, 2012
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HETEROARYL CO...
- Publication number 20110245245
- Publication date Oct 6, 2011
- Signal Pharmaceuticals, LLC.
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATMENT USING HETEROARYL COMPOUNDS AND COMPOSITIONS TH...
- Publication number 20110224217
- Publication date Sep 15, 2011
- Signal Pharmaceuticals, LLC.
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20110137028
- Publication date Jun 9, 2011
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCI...
- Publication number 20100216781
- Publication date Aug 26, 2010
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATM...
- Publication number 20100093698
- Publication date Apr 15, 2010
- Sogole Bahmanyar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl compounds, compositions thereof, and methods of treatmen...
- Publication number 20090042890
- Publication date Feb 12, 2009
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl compounds, compositions thereof, and methods of treatmen...
- Publication number 20090023724
- Publication date Jan 22, 2009
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY

Jennifer RIGGS

Person

Patents Grantslast 30 patents

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Methods of treating a cancer using substituted pyrrolopyrimidine co...

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Halogen substituted pyrazines as intermediates of mTOR kinase inhib...

Methods of synthesis and purification of heteroaryl compounds

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Methods of synthesis and purification of heteroaryl compounds

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...

Methods of treatment using heteroaryl compounds and compositions th...

Methods of treatment comprising the administration of heteroaryl co...

Aminotriazolopyridines, compositions thereof, and methods of treatm...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indicat...

Heteroaryl compounds, compositions thereof, and methods of treatmen...

Heteroaryl compounds, compositions thereof, and methods of treatmen...

Patents Applicationslast 30 patents

WEE1 Degrading Compounds and Uses Thereof

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE CO...

SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

METHODS OF TREATING A CANCER USING SUBSTITUTED PYRROLOPYRIMIDINE CO...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...

SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATM...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...

METHODS OF TREATMENT COMPRISING THE ADMINISTRATION OF HETEROARYL CO...

METHODS OF TREATMENT USING HETEROARYL COMPOUNDS AND COMPOSITIONS TH...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCI...

AMINOTRIAZOLOPYRIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATM...

Heteroaryl compounds, compositions thereof, and methods of treatmen...

Heteroaryl compounds, compositions thereof, and methods of treatmen...